Bal Pharma Limited
NSE: BALPHARMA.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Shailesh Dheerajmal Siroya
- Employees
- 868
- Headquarters
- Bengaluru, India
- IPO year
- 2006
- Market cap
- ₹1.3B
- Website
- https://www.balpharma.com
Loading BALPHARMA…
Loading profile data…Frequently asked questions about BALPHARMA
What does Bal Pharma Limited (BALPHARMA.NS) do?
Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health produ...
Where does BALPHARMA.NS trade?
Bal Pharma Limited (BALPHARMA.NS) trades on the National Stock Exchange of India.
What sector is BALPHARMA.NS in?
Bal Pharma Limited (BALPHARMA.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Bal Pharma Limited?
Shailesh Dheerajmal Siroya is the chief executive officer of Bal Pharma Limited (BALPHARMA.NS).
Where is Bal Pharma Limited headquartered?
Bal Pharma Limited is headquartered in India.
Does BALPHARMA.NS pay a dividend?
Yes — Bal Pharma Limited (BALPHARMA.NS) paid a trailing twelve-month dividend of INR 1.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BALPHARMA.NS go public?
Bal Pharma Limited (BALPHARMA.NS) completed its initial public offering in 2006.